Moteur de recherche d’entreprises européennes

Financement de l’UE (7 199 560 €) : Développer des cultures polyvalentes de Nicotiana pour l’agriculture moléculaire à l’aide de nouvelles techniques de sélection végétale Hor 01/01/2018 Programme de recherche et d'innovation de l'UE « Horizon »

Vue d’ensemble

Texte

Développer des cultures polyvalentes de Nicotiana pour l’agriculture moléculaire à l’aide de nouvelles techniques de sélection végétale

A group of New Plant Breeding Techniques (NPBT) has opened unprecedented opportunities in agriculture. Those NPBTs are at least as efficient and often more precise than previous traditional and GM techniques, while circumventing the introduction of heritable transgenes from distant species in the plant genome. Properly communicated, NPBTs are expected to gain wide acceptance, especially when applied to breeding objectives which are seen as beneficial for the society. A well-perceived objective is Molecular Farming, which refers to the use of plants for the production of valuable biomolecules (e. g. biopharmaceuticals). Cultivated tobacco (Nicotiana tabacum) and its close Australian relative Nicotiana benthamiana, are preferred species in Molecular Farming due to their favourable features: non-food crops, easy tissue regeneration, high productivity, rich secondary metabolism and availability of genetic tools. In sharp contrast, traditional tobacco cultivation is in serious decline in the EU, causing serious social problems in many rural areas. NEWCOTIANA aims to revitalize those areas by breeding efficient Nicotiana biofactories of high-value non-smoking products as alternatives for traditional tobacco crops. NEWCOTIANA will develop the most advanced tobacco NPBTs toolbox, easily transferable to other plants. This will position EU in the avant-garde of breeding innovation. This toolbox will be used to create elite multipurpose Nicotiana varieties improved in product-specific traits (bioproduct quality, stability and yield), next to more general traits as biomass, resilience and biosafety. The “Newcotiana” varieties will be carefully tested in relevant pre-industrial environments for the production of end-value chemicals, namely proteins and metabolites for health and nutriceutical use. Ethical, social and legal aspects will be closely monitored and public and stakeholder engagement will be assured using innovative science communication methodologies.


Agencia Estatal Consejo Superior de Investigaciones Cientificas 702 581 €
Agenzia Nazionale Per LE Nuove Tecnologie, L'Energia E LO Sviluppo Economico Sostenibile 465 000 €
Asociacion Empresarial de Investigacion Centro Tecnologico Nacional Agroalimentario Extremadura 292 108 €
Biofaction KG 338 131 €
Dermopartners SL 0,00 €
Fraunhofer Gesellschaft ZUR Forderung DER Angewandten Forschung e. V. 495 514 €
Idoasis 2002 SL 343 875 €
John Innes Centre 349 793 €
Karlsruher Institut Fuer Technologie 388 271 €
Leibniz-Institut FUR Pflanzenbiochemie 251 250 €
MAX-Planck-Gesellschaft ZUR Forderung DER Wissenschaften e. V. 576 125 €
Natac Biotech SL 0,00 €
Neutral Supply Chain Ltd. 319 063 €
Philip Morris Products SA 306 250 €
Queensland University OF Technology - QLD QUT 0,00 €
Royal Holloway and Bedford New College 459 863 €
Sesderma SL 191 988 €
St George's Hospital Medical School 562 823 €
The Chancellor, Masters and Scholars of the University of Oxford 371 321 €
Universitaet Fuer Bodenkultur Wien 426 131 €
VIB VZW 359 475 €

https://cordis.europa.eu/project/id/760331

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.